Switching Breast Cancer Drugs May Boost Survival
(Heal


HealthDay - TUESDAY, Feb. 13 (HealthDay News) -- Switching to newer breast
cancer drugs, called aromatase inhibitors, after two to three years of
treatment with tamoxifen may extend disease-free survival and slightly
reduce the risk of death in women who've been treated for early stage
disease, an international study finds.